Tasigna Lawsuit FAQs
Answers to the Most Common Tasigna Atherosclerosis Lawsuit Questions
This page features answers to common Tasigna lawsuit questions which apply to most Tasigna atherosclerosis claims. To speak about your circumstances in detail, contact our firm. Our team of lawyers providing representation for Tasigna lawsuit claims is offering free, no obligation Tasigna side effects lawsuit case review. Simply contact our firm and one of our experienced attorneys handling national Tasigna lawsuit claims will contact you to answer your questions, completely free of charge.
Does it cost anything for you to review my case?
We will always listen to your circumstances and give you our analysis of your case without any cost or further obligation.
Who is eligible to make a Tasigna atherosclerosis claim or file a Tasigna lawsuit against Novartis?
Any person or family member of a person who has suffered from peripheral arterial disease, atherosclerosis, circulatory problems or limb amputation from Tasigna may be eligible to make a claim by filing a Tasigna lawsuit against the drugmaker.
Aren't most drug and products liability lawsuits just class action lawsuits where the plaintiff receives very little money?
The majority of our drug cases are handled as a MDL, or Multi-District Litigation, where each plaintiff receives a settlement based upon the individual injuries and damages incurred by each plaintiff.
What does it cost to file a Tasigna lawsuit?
Our firm will represent all persons involved in a Tasigna lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. To receive your free, no-obligation consultation, contact our firm by using the online chat feature or contact form on this site. One of our attorneys handling Tasigna atherolscerosis lawsuits will contact you to answer any of your questions.
Who is most at risk for peripheral arterial disease, atherosclerosis, limb amputation or other vascular problems from Tasigna?
Anyone who is prescribed Tasigna--most often to treat chronic myeloid leukemia--is at risk for developing circulatory problems such as atherosclerosis or peripheral arterial disease. Tasigna causes the buildup of white blood cells and fibrofatty plaque in the arteries. Essentially, through its means of treatment, Tasigna causes the arterial walls to thicken, narrowing the channels through which blood can flow. Serious and life-threatening conditions can result, including tissue death, the need for limb amputation, and atherosclerosis.
What time limits apply to filing a Tasigna lawsuit?
Most states have Tasigna lawsuit time limits; however, the majority of all persons having taken Tasigna and developed circulatory problems will fall within those time limits if they contact an attorney in the near future. For specific time limits for your claim, please fill out the form at right and one of our lawyers will contact you as quickly as possible, usually within the hour.
We're not the type of people who sue; do we really need to file a lawsuit?
If a member of your family suffered a serious injury or health problem as a result of a defective product or dangerous drug, long-term, or even life-long, medical care may be required. This could be incredibly expensive and since medical costs are continually rising may be largely unknown at the time of settlement or trial. If a member of your family died due to a defective product or dangerous drug, no amount of money can undo that wrong. It is our fervent hope that every defective products, drug or other medication lawsuit we file can serve to make the manufacturer take note of the loss and pain its product has caused. When that fails to make a company take action in the form of a product recall, greater warnings about its use and ultimately making safer products, we rely on their profit motivation to make them do the right thing. Unfortunately, in all too many cases it is only the fear of lawsuits and large settlements and verdicts that makes a company become a better corporate citizen.
Onder Law Has Been Covered By: